查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375472

生物樣本庫市場：按產品、樣本類型、儲存類型、應用和最終用戶 - 2023-2030 年全球預測

Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物銀行市場預計將從 2022 年的 634.5 億美元增至 2030 年的 1,527.5 億美元，預測期內年複合成長率為 11.60%。

全球生物樣本庫市場

主要市場統計
市場金額：基準年 [2022] 634.5億美元
預計市場價值 [2023] 703.3億美元
預計市場量[2030] 1527.5億美元
年複合成長率（%） 11.60%
生物樣本庫市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣是評估生物樣本庫市場的重要工具。透過分析與業務策略和產品滿意度相關的關鍵指標來全面評估供應商。這使得使用者能夠根據自己的具體資訊做出明智的決策。進階分析將供應商分為四個像限，每個象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。這個富有洞察力的框架使決策者能夠充滿信心地駕馭市場。

市場佔有率分析

市場佔有率分析為供應商的市場形勢提供了寶貴的見解。評估對整體收益、客戶群和其他關鍵指標的影響可以全面了解公司的業績及其面臨的競爭環境。該分析還揭示了研究期間的競爭水平，例如市場佔有率成長、碎片化、主導地位和行業整合。

該報告對以下幾個方面提供了寶貴的見解：

1.市場滲透：提供有關市場動態和主要企業產品的全面資訊。

2. 市場開拓：詳細分析新興和成熟細分市場的滲透情況，以突顯利潤豐厚的商機。

3. 市場多元化：有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

5. 產品開發與創新：對未來技術、研發活動和突破性產品開發的智慧洞察。

本報告解決了以下關鍵問題：

1. 生物銀行市場的市場規模與預測是多少？

2. 生物樣本庫市場中哪些產品、細分市場、應用和領域具有最高的投資潛力？

3.生物樣本庫市場的競爭策略架構是什麼？

4. 生物樣本庫市場的最新技術趨勢和法律規範是什麼？

5. 生物樣本庫市場主要供應商的市場佔有率為何？

6. 進入生物樣本庫市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 各國慢性病負擔日益加重以及需要更好的醫療基礎設施
      • 擴大私人和公共對藥物研究的投資
      • 人們對再生醫學和政府配合措施的認知不斷增強
    • 抑制因素
      • 由於生物樣本庫的分散性質而導致程序統一的相關問題
    • 機會
      • 正在進行的研究以改進和確保生物樣本庫資料收集和分析的標準化
      • 新的重點是生物樣本庫的永續性和成像生物樣本庫的發展
    • 任務
      • 與生物樣本庫相關的道德和法律問題
  • 市場區隔分析
    • 產品：擴展軟體整合以簡化生物樣本庫操作
    • 樣本類型：增加核酸樣本在基因研究的使用
    • 儲存類型：效率和可擴展性使自動化儲存系統日益受到重視
    • 最終用戶：擴大製藥業生物庫的藥物開發
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 生物樣本庫市場：依產品

  • 介紹
  • 消耗品
  • 設備與設備
  • 服務
  • 軟體

第7章 生物樣本庫市場：依樣本類型

  • 介紹
  • 體液
  • 血液製品
  • 細胞株
  • 人體組織
  • 核酸

第8章 生物樣本庫市場：依儲存類型

  • 介紹
  • 自動的
  • 手動的

第9章 生物樣本庫市場：依應用分類

  • 介紹
  • 臨床調查
  • 生命科學研究
  • 再生醫學

第10章 生物樣本庫市場：按最終用戶分類

  • 介紹
  • 學術研究所
  • 醫院
  • 製藥和生物技術

第11章美洲生物樣本庫市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太生物樣本庫市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的生物樣本庫市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情境分析：主要企業
    • 併購
    • 合約、合作和夥伴關係
    • 投資、資金籌措

第15章競爭組合

  • 主要企業簡介
    • AMS Biotechnology（Europe）Limited
    • ASKION GmbH
    • Avantor, Inc.
    • Azenta Life Sciences
    • Bay Biosciences LLC
    • Becton, Dickinson and Company
    • BioIVT LLC
    • BioKryo by L'AIR LIQUIDE SA
    • BocaBio
    • Charles River Laboratories International, Inc.
    • Cryoport Systems, LLC
    • CTIBiotech
    • Cureline, Inc.
    • Firalis Group
    • Greiner AG
    • Hamilton Company
    • Merck KgaA
    • Micronic Holding BV
    • PHC Holdings Corporation
    • Promega Corporation
    • ProteoGenex
    • QIAGEN NV
    • Sopachem NV/SA
    • SPT Labtech Ltd.
    • STEMCELL Technologies Inc.
    • Taylor-Wharton
    • Tecan Trading AG
    • Thermo Fisher Scientific Inc.
    • UK Biobank Limited
    • US Biolab Corporation, Inc.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-961BA04A2DC4

The Biobanking Market is projected to reach USD 152.75 billion by 2030 from USD 63.45 billion in 2022, at a CAGR of 11.60% during the forecast period.

Global Biobanking Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 63.45 billion
Estimated Year Value [2023] USD 70.33 billion
Forecast Year Value [2030] USD 152.75 billion
CAGR (%) 11.60%
Biobanking Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biobanking Market.

Based on Product, market is studied across Consumables, Equipment & Instruments, Services, and Software. The Services is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids. The Biological Fluids is projected to witness significant market share during forecast period.

Based on Storage Type, market is studied across Automated and Manual. The Automated is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine. The Regenerative Medicine is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceutical & Biotechnology. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.91% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biobanking Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biobanking Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L'AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Biobanking Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Biobanking Market?

3. What is the competitive strategic window for identifying opportunities in the Biobanking Market?

4. What are the latest technology trends and regulatory frameworks in the Biobanking Market?

5. What is the market share of the leading vendors in the Biobanking Market?

6. Which modes and strategic moves are suitable for entering the Biobanking Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biobanking Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
      • 5.1.1.2. Growing private and public investments in pharmaceutical research
      • 5.1.1.3. Rising awareness and government initiatives in regenerative medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
      • 5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and legal concerns associated with biobanking
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding software integration to facilitate the biobanking operations
    • 5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
    • 5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
    • 5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biobanking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment & Instruments
  • 6.4. Services
  • 6.5. Software

7. Biobanking Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Biological Fluids
  • 7.3. Blood Products
  • 7.4. Cell Lines
  • 7.5. Human Tissues
  • 7.6. Nucleic Acids

8. Biobanking Market, by Storage Type

  • 8.1. Introduction
  • 8.2. Automated
  • 8.3. Manual

9. Biobanking Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Research
  • 9.3. Life Science Research
  • 9.4. Regenerative Medicine

10. Biobanking Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Hospitals
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Biobanking Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biobanking Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biobanking Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player
    • 14.3.1. Merger & Acquisition
      • 14.3.1.1. Crown Bioscience to Acquire Indivumed's Service Business and Supporting Biobank
    • 14.3.2. Agreement, Collaboration, & Partnership
      • 14.3.2.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
    • 14.3.3. Investment & Funding
      • 14.3.3.1. CNIO biobank receives EUR 800,000 from the EU

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AMS Biotechnology (Europe) Limited
    • 15.1.2. ASKION GmbH
    • 15.1.3. Avantor, Inc.
    • 15.1.4. Azenta Life Sciences
    • 15.1.5. Bay Biosciences LLC
    • 15.1.6. Becton, Dickinson and Company
    • 15.1.7. BioIVT LLC
    • 15.1.8. BioKryo by L'AIR LIQUIDE S.A.
    • 15.1.9. BocaBio
    • 15.1.10. Charles River Laboratories International, Inc.
    • 15.1.11. Cryoport Systems, LLC
    • 15.1.12. CTIBiotech
    • 15.1.13. Cureline, Inc.
    • 15.1.14. Firalis Group
    • 15.1.15. Greiner AG
    • 15.1.16. Hamilton Company
    • 15.1.17. Merck KgaA
    • 15.1.18. Micronic Holding B.V.
    • 15.1.19. PHC Holdings Corporation
    • 15.1.20. Promega Corporation
    • 15.1.21. ProteoGenex
    • 15.1.22. QIAGEN N.V.
    • 15.1.23. Sopachem NV/SA
    • 15.1.24. SPT Labtech Ltd.
    • 15.1.25. STEMCELL Technologies Inc.
    • 15.1.26. Taylor-Wharton
    • 15.1.27. Tecan Trading AG
    • 15.1.28. Thermo Fisher Scientific Inc.
    • 15.1.29. UK Biobank Limited
    • 15.1.30. US Biolab Corporation, Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOBANKING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOBANKING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BIOBANKING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BIOBANKING MARKET DYNAMICS
  • FIGURE 7. BIOBANKING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BIOBANKING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
  • FIGURE 10. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2022 VS 2030 (%)
  • FIGURE 12. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BIOBANKING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 14. BIOBANKING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. BIOBANKING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 16. BIOBANKING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOBANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 237. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 238. BIOBANKING MARKET LICENSE & PRICING